US Stock MarketDetailed Quotes

TSBX Turnstone Biologics

Watchlist
  • 0.480
  • -0.002-0.41%
Close Dec 13 16:00 ET
11.10MMarket Cap-0.15P/E (TTM)

Turnstone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.44%-17.58M
-8.40%-15.93M
-1.69%-17.46M
6.91%-66.15M
20.52%-15.5M
-56.39%-18.79M
36.36%-14.69M
-4.35%-17.17M
-55.74%-71.06M
-19.51M
Net income from continuing operations
1.66%-17.03M
0.91%-21.3M
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
---13.67M
Operating gains losses
----
----
47.37%-20K
--324K
--0
--338K
--24K
---38K
----
----
Depreciation and amortization
-29.86%491K
-31.78%498K
-28.21%509K
-28.27%2.8M
-44.39%659K
-34.76%700K
-21.67%730K
-0.28%709K
180.65%3.9M
--1.19M
Other non cash items
41.72%-373K
-180.19%-594K
-208.98%-791K
-2,001.02%-2.06M
-292.98%-951K
-1,900.00%-640K
-416.42%-212K
-334.86%-256K
-108.42%-98K
---242K
Change In working capital
62.85%-1.41M
-11.15%4.38M
107.12%1.37M
69.08%-17.92M
102.23%211K
-5.43%-3.8M
112.67%4.93M
-222.78%-19.26M
32.41%-57.97M
---9.48M
-Change in receivables
--0
--0
-95.43%194K
523.94%8.53M
100.54%23K
-97.20%33K
1,656.43%4.23M
396.49%4.25M
14.92%-2.01M
---4.29M
-Change in prepaid assets
91.28%-257K
52.73%1.12M
243.75%115K
316.24%426K
231.39%2.72M
-179.93%-2.95M
256.41%732K
94.05%-80K
92.62%-197K
---2.07M
-Change in payables and accrued expense
-111.02%-1.61M
693.78%3.19M
125.64%676K
-207.13%-4.52M
-204.24%-1.52M
69.06%-762K
6,600.00%402K
-452.83%-2.64M
-179.65%-1.47M
--1.46M
-Change in other current assets
380.58%495K
129.90%125K
336.81%431K
-373.72%-1.5M
-152.21%-1M
-84.79%103K
---418K
---182K
--548K
--1.92M
-Change in other current liabilities
81.39%-43K
-194.44%-53K
96.62%-44K
10.37%-1.56M
98.27%-6K
74.53%-231K
94.75%-18K
-842.03%-1.3M
-175.83%-1.74M
---347K
-Change in other working capital
----
----
----
63.64%-19.31M
--0
--0
--0
-297.08%-19.31M
35.20%-53.1M
---6.16M
Cash from discontinued investing activities
Operating cash flow
6.44%-17.58M
-8.40%-15.93M
-1.69%-17.46M
6.91%-66.15M
20.52%-15.5M
-56.39%-18.79M
36.36%-14.69M
-4.35%-17.17M
-55.74%-71.06M
---19.51M
Investing cash flow
Cash flow from continuing investing activities
157.38%24.25M
536.67%18.94M
-14.58%14.1M
-88.14%-28.09M
-191.47%-5.31M
-146.46%-42.26M
203.80%2.98M
2,398.05%16.5M
-346.00%-14.93M
5.8M
Net PPE purchase and sale
100.37%1K
-70.21%-80K
80.80%-144K
84.58%-797K
366.67%272K
88.21%-272K
97.81%-47K
-22.35%-750K
-51.79%-5.17M
---102K
Net investment purchase and sale
157.75%24.25M
529.42%19.02M
-17.46%14.24M
-179.61%-27.3M
-194.49%-5.58M
-182.96%-41.99M
520.31%3.02M
16,528.57%17.25M
-16,931.03%-9.76M
--5.9M
Cash from discontinued investing activities
Investing cash flow
157.38%24.25M
536.67%18.94M
-14.58%14.1M
-88.14%-28.09M
-191.47%-5.31M
-146.46%-42.26M
203.80%2.98M
2,398.05%16.5M
-346.00%-14.93M
--5.8M
Financing cash flow
Cash flow from continuing financing activities
-99.92%59K
81.95%-48K
0
3,000.83%77.05M
-3,480.00%-169K
2,885.34%78.3M
-290.00%-266K
-8,250.00%-815K
-103.32%-2.66M
5K
Net common stock issuance
----
----
----
--77.84M
---179K
----
----
----
--0
--0
Cash dividends paid
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
1,366.67%44K
--0
-33.12%105K
100.00%10K
350.00%9K
-97.86%3K
730.00%83K
-53.69%157K
--5K
Net other financing activities
----
----
----
68.08%-898K
--0
--269K
---269K
---898K
---2.81M
--0
Cash from discontinued financing activities
Financing cash flow
-99.92%59K
81.95%-48K
--0
3,000.83%77.05M
-3,480.00%-169K
2,885.34%78.3M
-290.00%-266K
-8,250.00%-815K
-103.32%-2.66M
--5K
Net cash flow
Beginning cash position
-19.08%17.52M
-56.74%14.55M
-48.98%17.91M
-71.63%35.11M
-20.33%38.89M
-73.21%21.65M
-68.45%33.63M
-71.63%35.11M
33.39%123.76M
--48.82M
Current changes in cash
-60.96%6.73M
124.77%2.97M
-126.60%-3.37M
80.60%-17.2M
-53.09%-20.98M
153.94%17.25M
53.58%-11.98M
91.35%-1.49M
-386.18%-88.65M
---13.7M
End cash Position
-37.65%24.25M
-19.08%17.52M
-56.74%14.55M
-48.98%17.91M
-48.98%17.91M
-20.33%38.89M
-73.21%21.65M
-68.45%33.63M
-71.63%35.11M
--35.11M
Free cash flow
7.72%-17.58M
-8.30%-16.03M
2.47%-17.6M
11.58%-67.4M
20.94%-15.5M
-32.99%-19.05M
41.34%-14.8M
-5.75%-18.05M
-55.46%-76.23M
---19.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.44%-17.58M-8.40%-15.93M-1.69%-17.46M6.91%-66.15M20.52%-15.5M-56.39%-18.79M36.36%-14.69M-4.35%-17.17M-55.74%-71.06M-19.51M
Net income from continuing operations 1.66%-17.03M0.91%-21.3M-28,966.18%-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M100.54%68K-192.68%-30.83M---13.67M
Operating gains losses --------47.37%-20K--324K--0--338K--24K---38K--------
Depreciation and amortization -29.86%491K-31.78%498K-28.21%509K-28.27%2.8M-44.39%659K-34.76%700K-21.67%730K-0.28%709K180.65%3.9M--1.19M
Other non cash items 41.72%-373K-180.19%-594K-208.98%-791K-2,001.02%-2.06M-292.98%-951K-1,900.00%-640K-416.42%-212K-334.86%-256K-108.42%-98K---242K
Change In working capital 62.85%-1.41M-11.15%4.38M107.12%1.37M69.08%-17.92M102.23%211K-5.43%-3.8M112.67%4.93M-222.78%-19.26M32.41%-57.97M---9.48M
-Change in receivables --0--0-95.43%194K523.94%8.53M100.54%23K-97.20%33K1,656.43%4.23M396.49%4.25M14.92%-2.01M---4.29M
-Change in prepaid assets 91.28%-257K52.73%1.12M243.75%115K316.24%426K231.39%2.72M-179.93%-2.95M256.41%732K94.05%-80K92.62%-197K---2.07M
-Change in payables and accrued expense -111.02%-1.61M693.78%3.19M125.64%676K-207.13%-4.52M-204.24%-1.52M69.06%-762K6,600.00%402K-452.83%-2.64M-179.65%-1.47M--1.46M
-Change in other current assets 380.58%495K129.90%125K336.81%431K-373.72%-1.5M-152.21%-1M-84.79%103K---418K---182K--548K--1.92M
-Change in other current liabilities 81.39%-43K-194.44%-53K96.62%-44K10.37%-1.56M98.27%-6K74.53%-231K94.75%-18K-842.03%-1.3M-175.83%-1.74M---347K
-Change in other working capital ------------63.64%-19.31M--0--0--0-297.08%-19.31M35.20%-53.1M---6.16M
Cash from discontinued investing activities
Operating cash flow 6.44%-17.58M-8.40%-15.93M-1.69%-17.46M6.91%-66.15M20.52%-15.5M-56.39%-18.79M36.36%-14.69M-4.35%-17.17M-55.74%-71.06M---19.51M
Investing cash flow
Cash flow from continuing investing activities 157.38%24.25M536.67%18.94M-14.58%14.1M-88.14%-28.09M-191.47%-5.31M-146.46%-42.26M203.80%2.98M2,398.05%16.5M-346.00%-14.93M5.8M
Net PPE purchase and sale 100.37%1K-70.21%-80K80.80%-144K84.58%-797K366.67%272K88.21%-272K97.81%-47K-22.35%-750K-51.79%-5.17M---102K
Net investment purchase and sale 157.75%24.25M529.42%19.02M-17.46%14.24M-179.61%-27.3M-194.49%-5.58M-182.96%-41.99M520.31%3.02M16,528.57%17.25M-16,931.03%-9.76M--5.9M
Cash from discontinued investing activities
Investing cash flow 157.38%24.25M536.67%18.94M-14.58%14.1M-88.14%-28.09M-191.47%-5.31M-146.46%-42.26M203.80%2.98M2,398.05%16.5M-346.00%-14.93M--5.8M
Financing cash flow
Cash flow from continuing financing activities -99.92%59K81.95%-48K03,000.83%77.05M-3,480.00%-169K2,885.34%78.3M-290.00%-266K-8,250.00%-815K-103.32%-2.66M5K
Net common stock issuance --------------77.84M---179K--------------0--0
Cash dividends paid --0------------------0----------------
Proceeds from stock option exercised by employees --01,366.67%44K--0-33.12%105K100.00%10K350.00%9K-97.86%3K730.00%83K-53.69%157K--5K
Net other financing activities ------------68.08%-898K--0--269K---269K---898K---2.81M--0
Cash from discontinued financing activities
Financing cash flow -99.92%59K81.95%-48K--03,000.83%77.05M-3,480.00%-169K2,885.34%78.3M-290.00%-266K-8,250.00%-815K-103.32%-2.66M--5K
Net cash flow
Beginning cash position -19.08%17.52M-56.74%14.55M-48.98%17.91M-71.63%35.11M-20.33%38.89M-73.21%21.65M-68.45%33.63M-71.63%35.11M33.39%123.76M--48.82M
Current changes in cash -60.96%6.73M124.77%2.97M-126.60%-3.37M80.60%-17.2M-53.09%-20.98M153.94%17.25M53.58%-11.98M91.35%-1.49M-386.18%-88.65M---13.7M
End cash Position -37.65%24.25M-19.08%17.52M-56.74%14.55M-48.98%17.91M-48.98%17.91M-20.33%38.89M-73.21%21.65M-68.45%33.63M-71.63%35.11M--35.11M
Free cash flow 7.72%-17.58M-8.30%-16.03M2.47%-17.6M11.58%-67.4M20.94%-15.5M-32.99%-19.05M41.34%-14.8M-5.75%-18.05M-55.46%-76.23M---19.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List